S J Lee Selected Research

Hepatocellular Carcinoma (Hepatoma)

5/2015	Gα12 gep oncogene deregulation of p53-responsive microRNAs promotes epithelial-mesenchymal transition of hepatocellular carcinoma.
8/2012	Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI.
3/2006	Positive regulation of hepatic carnitine palmitoyl transferase 1A (CPT1A) activities by soy isoflavones and L-carnitine.
11/2001	Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT.
9/2001	Detection of hepatocellular carcinoma: combined T2-weighted and dynamic gadolinium-enhanced MRI versus combined CT during arterial portography and CT hepatic arteriography.
3/2001	Opacification of the intrahepatic portal veins during CT hepatic arteriography.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S J Lee Research Topics

Disease

29	Neoplasms (Cancer) 12/2022 - 01/2000
9	Breast Neoplasms (Breast Cancer) 01/2021 - 06/2000
8	Infections 06/2018 - 01/2000
7	Fibrosis (Cirrhosis) 03/2014 - 07/2000
7	Carcinoma (Carcinomatosis) 01/2007 - 03/2000
6	Bronchiolitis Obliterans Syndrome 01/2018 - 08/2006
6	Hematologic Neoplasms (Hematological Malignancy) 01/2017 - 01/2001
6	Hepatocellular Carcinoma (Hepatoma) 05/2015 - 03/2001
6	Neoplasm Metastasis (Metastasis) 07/2014 - 03/2000
5	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2018 - 01/2000
5	Parkinson Disease (Parkinson's Disease) 11/2001 - 01/2000
4	Disease Progression 01/2017 - 01/2000
4	Pain (Aches) 04/2016 - 11/2000
4	Obesity 04/2013 - 12/2001
4	Erythema 01/2012 - 01/2009
4	Thrombosis (Thrombus) 07/2010 - 02/2000
4	Carcinogenesis 11/2003 - 01/2001
3	Arthritis (Polyarthritis) 12/2022 - 12/2001
3	Stroke (Strokes) 01/2020 - 07/2000
3	Malaria 01/2017 - 06/2000
3	Hemolysis 01/2017 - 10/2001
3	Sepsis (Septicemia) 01/2017 - 07/2010
3	Acne Vulgaris 10/2015 - 02/2009
3	Anaplastic Thyroid Carcinoma 12/2013 - 01/2013
3	Inflammation (Inflammations) 11/2012 - 09/2000
3	Insulin Resistance 03/2012 - 12/2001
3	Adenocarcinoma 10/2011 - 07/2000
3	Pneumoperitoneum 12/2008 - 11/2000
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2004 - 07/2001
3	Hypothermia 07/2002 - 02/2000
3	Urinary Bladder Neoplasms (Bladder Cancer) 11/2001 - 10/2000
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2001 - 07/2000
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2022 - 01/2009
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2021 - 04/2004
2	Heart Failure 10/2019 - 08/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 06/2013
2	Fatigue 01/2018 - 01/2001
2	Atopic Dermatitis (Atopic Eczema) 01/2018 - 11/2007
2	Hemorrhage 01/2017 - 01/2001
2	Burns 01/2017 - 04/2008
2	Hematoma 01/2017 - 10/2003
2	Lymphoma (Lymphomas) 12/2016 - 10/2016
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2016 - 04/2004
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2016 - 05/2000
2	Glioma (Gliomas) 06/2015 - 04/2001
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2014 - 03/2010
2	Body Weight (Weight, Body) 01/2014 - 09/2001
2	Disseminated Intravascular Coagulation 10/2013 - 07/2010
2	Erectile Dysfunction 07/2013 - 03/2013
2	Rectal Neoplasms (Rectal Cancer) 09/2012 - 05/2012

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2001
5	Pharmaceutical PreparationsIBA 07/2021 - 01/2000
5	EnzymesIBA 03/2006 - 02/2000
4	Carbon DioxideIBA 12/2018 - 07/2002
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 02/2015
4	SteroidsIBA 02/2015 - 08/2001
4	GinsenosidesIBA 08/2013 - 09/2000
4	DNA (Deoxyribonucleic Acid)IBA 10/2011 - 03/2000
4	CalciumIBA 11/2007 - 01/2000
4	alpha-SynucleinIBA 11/2001 - 01/2000
3	AntibodiesIBA 12/2021 - 10/2001
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019 - 01/2014
3	Biological ProductsIBA 12/2018 - 01/2001
3	Therapeutic UsesIBA 03/2018 - 02/2001
3	gadolinium ethoxybenzyl DTPA FDA Link 01/2018 - 08/2012
3	Hemoglobins (Hemoglobin)IBA 08/2015 - 12/2001
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2015 - 03/2002
3	PlatinumIBA 12/2012 - 12/2001
3	MucinsIBA 09/2012 - 08/2000
3	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2012 - 10/2009
3	Thioacetamide (Thioacetamid)IBA 11/2009 - 01/2001
3	ImmunosorbentsIBA 10/2001 - 02/2000
3	Messenger RNA (mRNA)IBA 10/2001 - 04/2001
3	Contrast MediaIBA 03/2001 - 07/2000
2	AntioxidantsIBA 12/2022 - 01/2009
2	Immunoglobulin E (IgE)IBA 01/2018 - 03/2001
2	Deoxyglucose (2 Deoxy D glucose)IBA 06/2017 - 03/2016
2	Quinine (Quinson)FDA Link 01/2017 - 05/2012
2	ArtesunateIBA 01/2017 - 05/2012
2	Bevacizumab (Avastin)FDA Link 07/2014 - 12/2012
2	Simvastatin (Zocor)FDA LinkGeneric 07/2014 - 08/2010
2	Phosphotransferases (Kinase)IBA 04/2013 - 11/2001
2	CytokinesIBA 12/2012 - 10/2000
2	Interleukin-12 (IL 12)IBA 12/2012 - 03/2002
2	GadoliniumIBA 09/2012 - 09/2001

Therapy/Procedure

18	Therapeutics 01/2020 - 01/2000
8	Catheters 08/2017 - 01/2000
8	Cell Transplantation 12/2016 - 08/2007
7	Drug Therapy (Chemotherapy) 07/2021 - 03/2001
6	Lasers (Laser) 08/2014 - 09/2000
5	Transplantation 01/2017 - 01/2001
4	Aftercare (After-Treatment) 01/2015 - 09/2012
3	Ligation 12/2021 - 04/2001
3	Stem Cell Transplantation 07/2021 - 01/2001
3	Dye Lasers 01/2012 - 10/2009
3	Hematopoietic Stem Cell Transplantation 11/2006 - 12/2001
2	Transcranial Magnetic Stimulation 01/2018 - 06/2003
2	Solid-State Lasers 08/2014 - 09/2010
2	Stents 03/2013 - 11/2000
2	Neoadjuvant Therapy 09/2012 - 05/2012